Other therapy.
Comparing MammaPrint and BluePrint results between core needle biopsy and surgical resection breast cancer specimens
Publication: St Gallen ย Authors: M. Kleijn, J. McKelley, Read More
The FLEX real world data platform explores new gene expression profiles and investigator-initiated protocols in early stage breast cancer
Publication: Miami Breast Authors: Pat Whitworth, Jennifer A. Crozier, Robert Read More
Racial disparities within Basal-type breast cancer: clinical and molecular features of African American and Caucasian obese patients
ย PUBLICATION: SABCS 2020 AUTHORS: Dipali Sharma, Lisa E. Blumencranz, Read More
Molecular profiles and clinical-pathological features of Asian early-stage breast cancer patients
PUBLICATION: SABCS 2020 AUTHORS: Margaret Chen, Ava Kwong, Carolyn Hendricks, Read More
Comparing MammaPrint and BluePrint results between core needle biopsy and surgical resection breast cancer specimens
PUBLICATION: SABCS 2020 AUTHORS: Joseph McKelley, Jennifer Wei, Brian Hoxeng, Read More
Differential gene expression in Luminal type invasive lobular carcinoma and invasive ductal carcinoma by MammaPrint risk stratification
PUBLICATION: SABCS 2020 AUTHORS: Beth-Ann Lesnikoski, Jennifer A. Crozier, Gordan Read More
Differential gene expression and clinical utility of MammaPrint and BluePrint in male breast cancer patients
PUBLICATION: SABCS 2020 AUTHORS: Jennifer A. Crozier, Julie Barone, Kalyan Read More
The FLEX real world data platform explores new gene expression profiles and investigator-initiated protocols in early stagebreast cancer
PUBLICATION: SABCS 2020 AUTHORS: Laura Lee, Sami Diab, Julie Read More
ESMO 2020 – Hallmarks of Cancer
PUBLICATION: ESMO 2020 AUTHORS: Josien C. Haan, Rajith Bhaskaran, Lorenza Read More
Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trial
PUBLICATION: European Journal of Cancer AUTHORS: Valesca P. Retel, Read More
